Mix Hard-/Software
The robot for therapy and diagnostics
TEDIRO Healthcare Robotics GmbH
TEDIRO Healthcare Robotics GmbH is developing the world’s first mobile therapy and diagnostic robot, which is set to take over a variety of routine activities in clinics in the future. The initial focus is on AI-supported rehabilitation. TEDIRO relies on established robot navigation technologies and develops the medical applications as digital therapy and diagnostic procedures on the robot itself as well as in cooperation with partners.
TGFS has held a stake in the company since 2024. Other investors include bm|t as lead investor, a business angel and the medium-sized robotics manufacturer MetraLabs GmbH Neue Technologien und Systeme, from which TEDIRO was spun off.
Status
Active
Segment
Early stage
Headquarter
Leipzig/Ilmenau
Website
www.tediro.com
TGFS-Team
Paul Michalke
Friedemann Stier
Company news
TGFS and bm|t invest in TEDIRO Healthcare Robotics GmbH
TGFS and bm|t invest a seven-figure sum in TEDIRO Healthcare Robotics GmbH in an extended seed financing round. The aim is to bring the mobile therapy robot platform THERY to market as a medical product and thus support healthcare facilities in times of a shortage of skilled workers.
English 
German